ANGO AngioDynamics, Inc. Net Sales Margin

Historical sales margin levels combined with nanosecond pulsed ablation for bloodless tumor removal confirm the technological progress of AngioDynamics, Inc. (ANGO). The value of -10.10 reflects this status. Effective warehouse and supply chain management guarantee stable income, while expansion into oncological surgery successfully offsets stagnant demand for conventional catheters, maintaining overall business resilience.
Summary analytical data breakdowns for AngioDynamics Corp (ANGO)

To build a defensive portfolio, fundamental screening requires evaluating the net profit margin relative to total revenue, which allows for the measurement of actual cost management efficiency. The integral net margin indicator reflects the success of AngioDynamics, Inc. (ANGO) in optimizing its portfolio and promoting Auryon and NanoKnife systems, demonstrating the company's transition toward sustainable profitability by shedding low-margin assets.